Five-year overall and disease-free survival in 170 patients with pseudomyxoma peritonei from a perforated appendiceal tumor following complete tumor removal and intraperitoneal chemotherapy

被引：0
|
作者：
Mirnezami, A.
Yano, H.
Sexton, R.
Cecil, T.
Moran, B.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2008年 / 51卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
50
引用
收藏
页码：653 / 654
页数：2
相关论文
共 50 条
  • [1] Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours
    Lord, A.
    Shihab, O.
    Chandrakumaran, K.
    Cecil, T.
    Moran, B.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 14 - 14
  • [2] Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours
    Lord, A. C.
    Shihab, O.
    Chandrakumaran, K.
    Mohamed, F.
    Cecil, T. D.
    Moran, B. J.
    EJSO, 2015, 41 (03): : 396 - 399
  • [3] Overall and disease-free survival following complete cytoreduction and intraperitoneal chemotherapy for peritoneal surface malignancy, predominantly of appendiceal origin, in 95 patients
    Murphy, E
    Meade, B
    Sexton, R
    Cecil, T
    Moran, B
    BRITISH JOURNAL OF SURGERY, 2005, 92 : 112 - 112
  • [4] The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin
    Tan, G. H. C.
    Novo, C. A.
    Dayal, S.
    Chandrakumaran, K.
    Mohamed, F.
    Cecil, T.
    Moran, B. J.
    EJSO, 2017, 43 (02): : 388 - 394
  • [5] Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin
    Chandrakumaran, Kandiah
    Carr, Norman John
    Mohamed, Faheez
    Cecil, Thomas Desmond
    Moran, Brendan John
    JAMA SURGERY, 2023, 158 (05) : 522 - 530
  • [6] Complete cytoreduction for Pseudomyxoma peritonei results in long-term disease-free survival in most patients
    Meade, B
    Mukherjee, A
    Sexton, R
    Farquharson, SM
    Cecil, TD
    Moran, BJ
    BRITISH JOURNAL OF SURGERY, 2004, 91 : 136 - 136
  • [7] Multidisciplinary tumor clinic results in improved five year overall and disease-free survival in patients with colorectal cancer.
    Honaker, Michael
    Edwards, Ceazon
    Ballouz, Samer
    Wasvary, Harry
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin
    Rangarajan, Karan
    Chandrakumaran, Kandiah
    Dayal, Sanjeev
    Mohamed, Faheez
    Moran, Brendan J.
    Cecil, Thomas D.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2018, 34 (05) : 559 - 563
  • [9] The impact of BMI extremes on disease-free survival and overall survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Naffouje, Amer A.
    Tulla, Kiara A.
    Khalaf, Zaynab
    Salti, George, I
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (02) : 194 - 202
  • [10] Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients
    Taflampas, P.
    Dayal, S.
    Chandrakumaran, K.
    Mohamed, F.
    Cecil, T. D.
    Moran, B. J.
    EJSO, 2014, 40 (05): : 515 - 520
12345